The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Osiris Therapeutics Inc

Nasdaq: OSIR
Last

(U.S.) $5.59

Today's change-0.15 -2.61%
Updated May 26 3:36 PM -4GMT. Delayed by at least 15 minutes.
 

Osiris Therapeutics Inc

Nasdaq: OSIR
Last

(U.S.) $5.59

Today's change-0.15 -2.61%
Updated May 26 3:36 PM -4GMT. Delayed by at least 15 minutes.

Osiris Therapeutics Inc crosses below 20-day moving average

Osiris Therapeutics Inc closed sharply lower Friday, dropping (U.S.)$0.15 or 2.61% to (U.S.)$5.59 and crossing below its 20-day moving average. Shares have lost 6.05% over the last five days, but have gained 13.85% over the last year to date. This security has underperformed the S&P 500 by 15.09% during the last year.

Key company metrics

  • Open(U.S.) $5.76
  • Previous close(U.S.) $5.74
  • High(U.S.) $5.76
  • Low(U.S.) $5.53
  • Bid / Ask-- / --
  • YTD % change+13.85%
  • Volume41,280
  • Average volume (10-day)23,572
  • Average volume (1-month)47,307
  • Average volume (3-month)162,931
  • 52-week range(U.S.) $2.67 to (U.S.) $7.39
  • Beta1.31
  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) -$0.20
Updated May 26 3:36 PM -4GMT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue25242110
Total other revenue--------
Total revenue25242110
Gross profit2019169
Total cost of revenue5551
Total operating expense25221918
Selling / general / administrative17151316
Research & development2220
Depreciation / amortization--------
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total----00
Operating income022-8
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-122-8
Income after tax-111-8
Income tax, total0010
Net income-111-7
Total adjustments to net income--------
Net income before extra. items-111-8
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-111-8
Inc. avail. to common incl. extra. items-111-7
Diluted net income-111-7
Dilution adjustment--00--
Diluted weighted average shares34353534
Diluted EPS excluding extraordinary itemsvalue per share-0.020.030.04-0.22
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share-0.020.030.04-0.22